Medical Dosimetry
Volume 34, Issue 3 , Pages 256-260 , Autumn 2009

Dosimetric and Radiobiologic Comparison of 3D Conformal Versus Intensity Modulated Planning Techniques for Prostate Bed Radiotherapy

Received 15 May 2008 ,Accepted 23 October 2008.

References 

  1. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572–578
  2. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer:Aa randomized clinical trial. JAMA. 2006;296:2329–2335
  3. Luxton G, Hancock SL, Boyer AL. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 2004;59:267–284
  4. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther. Onkol. 2005;181:448–455
  5. Morganti AG, Valentini V, Mantello G, et al. Cost- and time-sparing simplified conformal therapy for prostate cancer: Is it feasible?. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:65–71
  6. Oh CE, Antes K, Darby M, et al. Comparison of 2D conventional, 3D conformal, and intensity-modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose to critical, uninvolved structures. Med. Dosim. 1999;24:255–263
  7. Ganswindt U, Paulsen F, Corvin S, et al. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:347–355
  8. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J. Clin. Oncol. 2006;24:1990–1996
  9. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002;53:1097–1105
  10. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J. Urol. 2001;166:876–881
  11. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA. 2005;294:1233–1239
  12. Anscher MS, Clough R, Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: The first 10 years. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:369–375
  13. Tudor GS. Comparison of rectal dose histograms under conditions of nonlinear isodoses. Phys. Med. Biol. 2007;52:275–289
  14. Bedford JL, Khoo VS, Oldham M, et al. A comparison of coplanar four-field techniques for conformal radiotherapy of the prostate. Radiother. Oncol. 1999;51:225–235
  15. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat. Res. Suppl. 1985;8:S13–S19
  16. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:109–122
  17. Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:123–135
  18. Ashman JB, Zelefsky MJ, Hunt MS, et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:765–771
  19. Sharma NK, Li T, Horwitz EM, et al. Intensity modulated radiation therapy reduces gastrointestinal morbidity in patients treated with androgen deprivation therapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007;69:S10
  20. Sanguineti G, Castellone P, Foppiano F, et al. Anatomic variations due to radical prostatectomy (Impact on target volume definition and dose-volume parameters of rectum and bladder). Strahlenther. Onkol. 2004;180:563–572
  21. Poortmans P, Bossi A, Vandeputte K, et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother. Oncol. 2007;84:121–127
  22. Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 1999;85:2460–2468
  23. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J. Clin. Oncol. 2008;26:2085–2092

PII: S0958-3947(08)00167-2

doi: 10.1016/j.meddos.2008.10.005

Medical Dosimetry
Volume 34, Issue 3 , Pages 256-260 , Autumn 2009

Article Tools

* Image Usage & Resolution